Two Cases of COVID-19 Reinfection in Turkey
Yıl: 2021 Cilt: 3 Sayı: 2 Sayfa Aralığı: 100 - 106 Metin Dili: İngilizce DOI: 10.36519/idcm.2021.59 İndeks Tarihi: 21-11-2021
Two Cases of COVID-19 Reinfection in Turkey
Öz: It is not clear whether re-infection by SARS-CoV-2 occurs as a rare event or not, but since the start of the pandemic limited number of re-infection has been reported. This study reports the clinical presentations and comperative genome analysis of two patients who were suspected of re-infection. The patients showed mild clinical symptoms and varied antibody test results in the two episodes of infections. New generation sequencing of the isolates revealed the presence of different mutations between isolates from the previous and last infections. Therefore it is important to monitor these mutations and assess their capacity of evading previously occurred antibodies.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1 Interim Guidance on Ending Isolation and Precautions for Adults with COVID-19 [Internet]. Centers for Disease Control and Prevention. (updated March 16, 2021; cited June 25, 2021). Available from: https://www.cdc.gov/coronavirus/2019-ncov/ hcp/duration-isolation.html#references
- 2 Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. Mar, 2021;27(3):315- 8. [CrossRef]
- 3 Threat Assessment Brief: Reinfection with SARS-CoV-2: considerations for public health response [Internet]. European Centre for Disease Prevention and Control (ECDC). (September 21, 2020; cited June 25, 2021). Available from: https://www.ecdc. europa.eu/en/publications-data/threat-assessment-brief-reinfection-sars-cov-2
- 4 Rehman S, Mahmood T, Aziz E, Batool R. Identification of novel mutations in SARS-COV-2 isolates from Turkey. Arch Virol. Dec, 2020;165(12):2937-44. [CrossRef]
- 5 Gómez-Carballa A, Bello X, Pardo-Seco J, Martinón-Torres F, Salas A. Mapping genome variation of SARS-CoV-2 worldwide highlights the impact of COVID-19 super-spreaders. Genome Res. Oct, 2020;30(10):1434-48. [CrossRef]
- 6 Zhang L, Jackson CB, Mou H, Ojha A, Peng H, Quinlan BD, et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. Nov 26, 2020;11(1):6013. [CrossRef]
- 7 Singh, B. Understanding the role of key point mutations in receptor binding domain of SARS-CoV-2 spike glycoprotein. Preprints 2020, 2020030394. [CrossRef]
- 8 To KK-W, Hung IF-N, Ip JP, Chu AW-H, Chan W-M, Tam AR, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. Aug 25, 2020;ciaa1275. [CrossRef]
- 9 Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, et al. Genomic evidence for reinfection with SARSCoV-2: a case study. Lancet Infect Dis. Jan, 2021;21(1):52- 8. [CrossRef]
- 10 West J, Everden S, Nikitas N. A case of COVID-19 reinfection in the UK. Clin Med (Lond). Jan, 2021;21(1):e52-e53. [CrossRef]
- 11 Torres DA, Ribeiro LDCB, Riello APFL, Horovitz DDG, Pinto LFR, Croda J. Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: Case report. J Med Virol. Apr, 2021;93(4):1857-9. [CrossRef]
- 12 Nachmias V, Fusman R, Mann S, Koren G. The first case of documented Covid-19 reinfection in Israel. IDCases. 2020; 22: e00970. [CrossRef]
- 13 Vora T, Vora P, Vora F, Sharma K, Desai HD. Symptomatic reinfection with COVID-19: A first from Western India. Journal of Family Medicine and Primary Care. Mar, 2021;10(3):1496- 8. [CrossRef]
- 14 Prado-Vivar B, Becerra-Wong M, Guadalupe JJ, Marquez S, Gutierrez B, Rojas-Silva P, et al. COVID-19 re-infection by a phylogenetically distinct SARS-CoV-2 variant, first confirmed event in South America [Internet]. SSRN. (September 8, 2021; cited June 25, 2021). [CrossRef] Available from: https://papers.ssrn. com/sol3/papers.cfm?abstract_id=3686174
- 15 Colson P, Finaud M, Levy N, Lagier JC, Raoult D. Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect. Apr, 2021;82(4):84-123. [CrossRef]
- 16 Prado-Vivar B, Becerra-Wong M, Guadalupe JJ, Márquez S, Gutierrez B, Rojas-Silva P, et al. A case of SARS-CoV-2 reinfection in Ecuador. Lancet Infect Dis. Jun, 2021;21(6):e142.
- 17 Madewell ZJ, Yang Y, Jr IML, Halloran ME, Dean NE. Longitudinal evaluation and decline of antibody responses in SARS CoV-2 infection. medRxiv [Preprint]. July 11, 2020. [CrossRef]
| APA | Akdemir Kalkan İ, Siraj Mohammed N, ÇINAR G, Gülten E, Sarıcaoğlu E, KARAHAN Z, BOZDAYI A, Azap A (2021). Two Cases of COVID-19 Reinfection in Turkey. , 100 - 106. 10.36519/idcm.2021.59 |
| Chicago | Akdemir Kalkan İrem,Siraj Mohammed Nejat,ÇINAR Güle,Gülten Ezgi,Sarıcaoğlu Elif mukime,KARAHAN Zeynep Ceren,BOZDAYI ABDURRAHMAN MITHAT,Azap Alpay Two Cases of COVID-19 Reinfection in Turkey. (2021): 100 - 106. 10.36519/idcm.2021.59 |
| MLA | Akdemir Kalkan İrem,Siraj Mohammed Nejat,ÇINAR Güle,Gülten Ezgi,Sarıcaoğlu Elif mukime,KARAHAN Zeynep Ceren,BOZDAYI ABDURRAHMAN MITHAT,Azap Alpay Two Cases of COVID-19 Reinfection in Turkey. , 2021, ss.100 - 106. 10.36519/idcm.2021.59 |
| AMA | Akdemir Kalkan İ,Siraj Mohammed N,ÇINAR G,Gülten E,Sarıcaoğlu E,KARAHAN Z,BOZDAYI A,Azap A Two Cases of COVID-19 Reinfection in Turkey. . 2021; 100 - 106. 10.36519/idcm.2021.59 |
| Vancouver | Akdemir Kalkan İ,Siraj Mohammed N,ÇINAR G,Gülten E,Sarıcaoğlu E,KARAHAN Z,BOZDAYI A,Azap A Two Cases of COVID-19 Reinfection in Turkey. . 2021; 100 - 106. 10.36519/idcm.2021.59 |
| IEEE | Akdemir Kalkan İ,Siraj Mohammed N,ÇINAR G,Gülten E,Sarıcaoğlu E,KARAHAN Z,BOZDAYI A,Azap A "Two Cases of COVID-19 Reinfection in Turkey." , ss.100 - 106, 2021. 10.36519/idcm.2021.59 |
| ISNAD | Akdemir Kalkan, İrem vd. "Two Cases of COVID-19 Reinfection in Turkey". (2021), 100-106. https://doi.org/10.36519/idcm.2021.59 |
| APA | Akdemir Kalkan İ, Siraj Mohammed N, ÇINAR G, Gülten E, Sarıcaoğlu E, KARAHAN Z, BOZDAYI A, Azap A (2021). Two Cases of COVID-19 Reinfection in Turkey. Infectious diseases and clinical microbiology (Online), 3(2), 100 - 106. 10.36519/idcm.2021.59 |
| Chicago | Akdemir Kalkan İrem,Siraj Mohammed Nejat,ÇINAR Güle,Gülten Ezgi,Sarıcaoğlu Elif mukime,KARAHAN Zeynep Ceren,BOZDAYI ABDURRAHMAN MITHAT,Azap Alpay Two Cases of COVID-19 Reinfection in Turkey. Infectious diseases and clinical microbiology (Online) 3, no.2 (2021): 100 - 106. 10.36519/idcm.2021.59 |
| MLA | Akdemir Kalkan İrem,Siraj Mohammed Nejat,ÇINAR Güle,Gülten Ezgi,Sarıcaoğlu Elif mukime,KARAHAN Zeynep Ceren,BOZDAYI ABDURRAHMAN MITHAT,Azap Alpay Two Cases of COVID-19 Reinfection in Turkey. Infectious diseases and clinical microbiology (Online), vol.3, no.2, 2021, ss.100 - 106. 10.36519/idcm.2021.59 |
| AMA | Akdemir Kalkan İ,Siraj Mohammed N,ÇINAR G,Gülten E,Sarıcaoğlu E,KARAHAN Z,BOZDAYI A,Azap A Two Cases of COVID-19 Reinfection in Turkey. Infectious diseases and clinical microbiology (Online). 2021; 3(2): 100 - 106. 10.36519/idcm.2021.59 |
| Vancouver | Akdemir Kalkan İ,Siraj Mohammed N,ÇINAR G,Gülten E,Sarıcaoğlu E,KARAHAN Z,BOZDAYI A,Azap A Two Cases of COVID-19 Reinfection in Turkey. Infectious diseases and clinical microbiology (Online). 2021; 3(2): 100 - 106. 10.36519/idcm.2021.59 |
| IEEE | Akdemir Kalkan İ,Siraj Mohammed N,ÇINAR G,Gülten E,Sarıcaoğlu E,KARAHAN Z,BOZDAYI A,Azap A "Two Cases of COVID-19 Reinfection in Turkey." Infectious diseases and clinical microbiology (Online), 3, ss.100 - 106, 2021. 10.36519/idcm.2021.59 |
| ISNAD | Akdemir Kalkan, İrem vd. "Two Cases of COVID-19 Reinfection in Turkey". Infectious diseases and clinical microbiology (Online) 3/2 (2021), 100-106. https://doi.org/10.36519/idcm.2021.59 |
